image description
image description
Tell A Friend

FinancialNews


  • 05-10-19

    Biotech facility to be established in KSA

    (MENAFN) A memorandum of understanding was secured between the Saudi Arabian Investment Authority (SAGIA) and South Korea-based GL Rapha Co.

    Under the USD320 million agreement, the two sides will join hands on the production of biological drugs in Saudi Arabia.

    SAGIA confirmed that the deal will lead to the establishment of a facility with a production capacity of thirty biotechnology products as well as the generation of five products over a five-year period.

    The facility, as SAGIA added, will include all phases of manufacturing the biological medicines that cover manufacturing raw materials.

    MENAFN0510201900450000ID1099088156

Follow us

RSS
Terms & Conditions  |  Privacy & Security  |  Contact Us  | Sitemap
© 2024 BBK  |  All Rights Reserved